Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

KIN

Kindred Biosciences (KIN)

Kindred Biosciences Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:KIN
DataHoraFonteTítuloCódigoCompanhia
14/02/202219:35Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:KINKindred Biosciences Inc
02/09/202107:05Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:KINKindred Biosciences Inc
30/08/202119:08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:KINKindred Biosciences Inc
30/08/202110:22Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:KINKindred Biosciences Inc
30/08/202110:09Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:KINKindred Biosciences Inc
30/08/202110:06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:KINKindred Biosciences Inc
30/08/202110:05Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:KINKindred Biosciences Inc
27/08/202118:37Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:KINKindred Biosciences Inc
10/08/202107:01Edgar (US Regulatory)Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a)NASDAQ:KINKindred Biosciences Inc
05/08/202117:15Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:KINKindred Biosciences Inc
21/07/202110:11Edgar (US Regulatory)Proxy Statement - Merger or Acquisition (definitive) (defm14a)NASDAQ:KINKindred Biosciences Inc
09/07/202118:31Edgar (US Regulatory)Proxy Statement - Merger or Acquisition (preliminary) (prem14a)NASDAQ:KINKindred Biosciences Inc
25/06/202117:33Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:KINKindred Biosciences Inc
25/06/202117:31Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:KINKindred Biosciences Inc
16/06/202119:45PR Newswire (US)ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Kindred Biosciences, Inc.NASDAQ:KINKindred Biosciences Inc
16/06/202108:35Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:KINKindred Biosciences Inc
16/06/202107:30Business WireElanco Announces Agreement to Acquire Kindred BiosciencesNASDAQ:KINKindred Biosciences Inc
02/06/202109:31PR Newswire (US)Kindred Biosciences Announces Positive Results from Pivotal Efficacy Study of Parvovirus Monoclonal Antibody for the Preventi...NASDAQ:KINKindred Biosciences Inc
25/05/202109:42PR Newswire (US)Kindred Biosciences to Present at Stifel 2021 Virtual Jaws & Paws Conference and LD Micro Invitational XINASDAQ:KINKindred Biosciences Inc
11/05/202117:03PR Newswire (US)Kindred Biosciences Announces First Quarter 2021 Financial ResultsNASDAQ:KINKindred Biosciences Inc
03/05/202109:42PR Newswire (US)Kindred Biosciences to Announce First Quarter 2021 Financial ResultsNASDAQ:KINKindred Biosciences Inc
29/04/202117:06Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:KINKindred Biosciences Inc
28/04/202109:32PR Newswire (US)Kindred Biosciences Announces Acceptance of Parvovirus Antibody Prophylaxis Study Data and Approval of Efficacy IndicationNASDAQ:KINKindred Biosciences Inc
20/04/202117:03PR Newswire (US)Kindred Biosciences Unveils Positive Results from its Long-Acting Interleukin-31 Antibody PK StudyNASDAQ:KINKindred Biosciences Inc
01/04/202118:14Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:KINKindred Biosciences Inc
16/03/202117:02PR Newswire (US)Kindred Biosciences Announces Fourth Quarter and Full Year 2020 Financial ResultsNASDAQ:KINKindred Biosciences Inc
08/03/202110:32PR Newswire (US)Kindred Biosciences to Announce Fourth Quarter and Full Year 2020 Financial ResultsNASDAQ:KINKindred Biosciences Inc
02/03/202110:31PR Newswire (US)Kindred Biosciences to Present at Barclays Global Healthcare Conference and H.C. Wainwright Global Life Sciences ConferenceNASDAQ:KINKindred Biosciences Inc
25/02/202110:01PR Newswire (US)Kindred Biosciences Announces Submission of Parvovirus Monoclonal Antibody Data for Prophylactic IndicationNASDAQ:KINKindred Biosciences Inc
16/02/202118:02PR Newswire (US)Kindred Biosciences to Present at the BofA Securities Animal Health Virtual SummitNASDAQ:KINKindred Biosciences Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:KIN